Connect Biopharma Holdings Ltd — All Filings
167 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
20-F
3
424B4
6-K
8-A12B
8-K
CERT
CORRESP
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-3/A
F-6
F-6 POS
POS AM
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | 3 | 0001193125-26-114092 | Mar 18, 2026 | — |
| 3 | FORM 3 | 0001602459-26-000002 | Mar 16, 2026 | — |
| 3 | FORM 3 | 0001384243-26-000006 | Mar 16, 2026 | — |
| 3 | FORM 3 | 0001828266-26-000004 | Mar 16, 2026 | — |
| 3 | FORM 3 | 0002115875-26-000002 | Mar 16, 2026 | — |
| 3 | FORM 3 | 0001267490-26-000002 | Mar 16, 2026 | — |
| 3 | FORM 3 | 0001420987-26-000002 | Mar 16, 2026 | — |
| 3 | FORM 3 | 0001241357-26-000002 | Mar 16, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-055654 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-055603 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001193125-26-055136 | Feb 17, 2026 | — |
| 8-K | 8-K | 0001835268-25-000061 | Dec 23, 2025 | Dec 17, 2025 |
| SCHEDULE 13G/A | — | 0001913491-25-000005 | Nov 28, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-300640 | Nov 26, 2025 | — |
| 144 | — | 0001193125-25-294111 | Nov 24, 2025 | — |
| 144 | — | 0001949846-25-000624 | Nov 21, 2025 | — |
| 144 | — | 0001968940-25-000009 | Nov 18, 2025 | — |
| 10-Q | 10-Q | 0001835268-25-000058 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001835268-25-000057 | Nov 12, 2025 | — |
| 144 | — | 0001949846-25-000514 | Oct 1, 2025 | — |
| 8-K | 8-K | 0001835268-25-000056 | Sep 16, 2025 | — |
| EFFECT | — | 9999999995-25-002945 | Sep 12, 2025 | — |
| POS AM | POS AM | 0001193125-25-200186 | Sep 10, 2025 | — |
| 10-Q | 10-Q | 0001835268-25-000052 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001835268-25-000051 | Aug 13, 2025 | — |
| 8-K | 8-K | 0001835268-25-000047 | Jul 22, 2025 | — |
| 8-K | 8-K | 0001835268-25-000044 | Jul 21, 2025 | Jul 18, 2025 |
| SCHEDULE 13D/A | — | 0000950170-25-097088 | Jul 21, 2025 | — |
| F-6 POS | — | 0000950127-25-000092 | Jul 18, 2025 | — |
| 8-K | 8-K | 0001835268-25-000039 | Jul 17, 2025 | Jul 16, 2025 |
| 8-K | 8-K | 0001628280-25-034551 | Jul 9, 2025 | — |
| EFFECT | — | 9999999995-25-002040 | Jun 26, 2025 | — |
| CORRESP | — | 0001193125-25-145761 | Jun 24, 2025 | — |
| UPLOAD | — | 0000000000-25-006235 | Jun 12, 2025 | — |
| 144 | — | 0001913491-25-000001 | Jun 11, 2025 | — |
| S-8 | S-8 | 0001193125-25-138485 | Jun 10, 2025 | — |
| F-3 | F-3 | 0001193125-25-138482 | Jun 10, 2025 | — |
| 10-Q | 10-Q | 0001835268-25-000035 | May 15, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001835268-25-000033 | May 15, 2025 | — |
| 8-K | 8-K | 0001835268-25-000029 | May 14, 2025 | — |
| 8-K | 8-K | 0001835268-25-000026 | May 13, 2025 | — |
| 8-K | 8-K | 0001835268-25-000019 | Apr 1, 2025 | — |
| 10-K | 10-K | 0001835268-25-000014 | Mar 31, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001835268-25-000013 | Mar 31, 2025 | — |
| 6-K | 6-K | 0001835268-25-000008 | Mar 28, 2025 | — |
| 6-K | 6-K | 0001628280-24-052323 | Dec 23, 2024 | Dec 10, 2024 |
| 6-K | 6-K | 0001835268-24-000027 | Sep 6, 2024 | — |
| 6-K | 6-K | 0001835268-24-000023 | Sep 5, 2024 | Jun 30, 2024 |
| 6-K | 6-K | 0001835268-24-000019 | Aug 2, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-24-173301 | Jul 1, 2024 | — |